BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 12505689)

  • 21. Endogenous cannabinoids: metabolism and their role in reproduction.
    Habayeb OM; Bell SC; Konje JC
    Life Sci; 2002 Mar; 70(17):1963-77. PubMed ID: 12148689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.
    Darmani NA
    J Pharmacol Exp Ther; 2002 Jan; 300(1):34-42. PubMed ID: 11752094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
    Pratt PF; Hillard CJ; Edgemond WS; Campbell WB
    Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The complexities of the cardiovascular actions of cannabinoids.
    Randall MD; Kendall DA; O'Sullivan S
    Br J Pharmacol; 2004 May; 142(1):20-6. PubMed ID: 15131000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
    Wagner JA; Járai Z; Bátkai S; Kunos G
    Eur J Pharmacol; 2001 Jul; 423(2-3):203-10. PubMed ID: 11448486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrograde signaling by endocannabinoids.
    Kreitzer AC; Regehr WG
    Curr Opin Neurobiol; 2002 Jun; 12(3):324-30. PubMed ID: 12049940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease.
    Navarro M; Rodríguez de Fonseca F
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):379-85. PubMed ID: 9974172
    [No Abstract]   [Full Text] [Related]  

  • 29. Anandamide--a new look on fatty acid ethanolamides.
    Berdyshev EV; Boichot E; Lagente V
    J Lipid Mediat Cell Signal; 1996 Dec; 15(1):49-67. PubMed ID: 9029374
    [No Abstract]   [Full Text] [Related]  

  • 30. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
    Sugiura T; Kondo S; Sukagawa A; Nakane S; Shinoda A; Itoh K; Yamashita A; Waku K
    Biochem Biophys Res Commun; 1995 Oct; 215(1):89-97. PubMed ID: 7575630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression.
    Mechoulam R
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):93-9. PubMed ID: 12052029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocannabinoids and the gut.
    Pinto L; Capasso R; Di Carlo G; Izzo AA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):333-41. PubMed ID: 12052047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous cannabinoid signaling.
    Piomelli D; Beltramo M; Giuffrida A; Stella N
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):462-73. PubMed ID: 9974178
    [No Abstract]   [Full Text] [Related]  

  • 34. Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells.
    Mombouli JV; Schaeffer G; Holzmann S; Kostner GM; Graier WF
    Br J Pharmacol; 1999 Apr; 126(7):1593-600. PubMed ID: 10323591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous cannabinoids mediate hypotension after experimental myocardial infarction.
    Wagner JA; Hu K; Bauersachs J; Karcher J; Wiesler M; Goparaju SK; Kunos G; Ertl G
    J Am Coll Cardiol; 2001 Dec; 38(7):2048-54. PubMed ID: 11738314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroscience. Stout guards of the central nervous system.
    Mechoulam R; Lichtman AH
    Science; 2003 Oct; 302(5642):65-7. PubMed ID: 14526067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response.
    De Petrocellis L; Melck D; Bisogno T; Milone A; Di Marzo V
    Neuroscience; 1999; 92(1):377-87. PubMed ID: 10392859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1.
    Stefano GB; Bilfinger TV; Rialas CM; Deutsch DG
    Pharmacol Res; 2000 Oct; 42(4):317-22. PubMed ID: 10987990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocannabinoids in the central nervous system--an overview.
    Fride E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocannabinoids: new targets for drug development.
    Di Marzo ; Bisogno T; De Petrocellis L
    Curr Pharm Des; 2000 Sep; 6(13):1361-80. PubMed ID: 10903398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.